We found that NK cells isolated from the blood of ARDS COVID-19 patients retained cytotoxic functions, and that incubation with monalizumab,5 an anti-NKG2A mAb blocking the inhibitory interaction with HLA-E, was able to unleash their killing ability (Fig. 1g). The gene discussed is KLRC1; the disease is COVID-19.